Anemia Market Research Reports

Anemia Market Research

Anemia, one of the more common blood disorders, occurs when the level of healthy red blood cells (RBCs) in the body reduces ... view more

RSS Sort By :
TITLE Price Buy Now More options

DelveInsight’s “Iron Deficiency Anemia - Market Insights, Epidemiology and Market Forecast – 2025” report provides an overview of the disease and in depth research related to Iron Deficiency Anemia for the 7MM (United States, Germany, France, Italy, ...

$ 5750


DelveInsight’s “Aplastic Anemia - Market Insights, Epidemiology and Market Forecast – 2025” Reports provides an overview of the disease and global market size of the Aplastic Anemia for the 7MM (United States, Germany, France, Italy, Spain and UK)...

$ 5750


Iron Deficiency Anemia Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, “Iron Deficiency Anemia Global Clinical Trials Review, H2, 2017" provides an overview of Iron Deficiency Anemia c...

$ 2500


This report studies the global Anemia Therapeutics market, analyzes and researches the Anemia Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global ...

$ 3300


It is a medical condition that is characterized by the decrease in RBC count. RBCs make up the blood, and its main function is to deliver oxygen from lungs to other tissues and carbon dioxide from other tissues back to the lungs. This function is ...

$ 3500


This report studies Iron Deficiency Anemia Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast ...

$ 3500


This report studies the global Anemia Drugs market, analyzes and researches the Anemia Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like...

$ 3300


In this report, the United States Iron Deficiency Anemia Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this r...

$ 3800


This report studies Sickle Cell Anemia Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2...

$ 3500


In this report, the global Iron Deficiency Anemia Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report i...

$ 2900


Chemotherapy Induced Anemia - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chemotherapy Induced Anemia - Pipeline Review, H2 2017, provides an overv...

$ 2000


In this report, the United States Sickle Cell Anemia Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this repor...

$ 3800


GlobalData's clinical trial report, "Fanconi Anemia Global Clinical Trials Review, H2, 2017" provides an overview of Fanconi Anemia clinical trials scenario. This report provides top line data relating to the clinical trials on Fanconi Anemia. Rep...

$ 2500


DelveInsight’s “Renal Anemia -Epidemiology Forecast, 2025” provides an overview of the epidemiology trends of Renal Anemia in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and fore...

$ 2950


DelveInsight’s “Iron Deficiency Anemia -Epidemiology Forecast, 2025” provides an overview of the epidemiology trends of Iron Deficiency Anemia in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology...

$ 2950


Iron Deficiency Anemia - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Iron Deficiency Anemia - Pipeline Review, H2 2017, provides an overview of the...

$ 2000


Increase in number of Hematology disease drug approvals from the regulatory bodies such as FDA in the US and EMA in EU is an emerging trend in the market. For instance, in June 2017, Novo Nordisk received FDA approval for its Rebinyn (Coagulation Fac...

$ 4000


DelveInsight “ Aplastic Anemia - Epidemiology Forecast To 2025” provides an overview of the epidemiology trends of Aplastic Anemia in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical ...

$ 2950


DelveInsight “ Chemotherapy Induced Anemia - Epidemiology Forecast To 2025” provides an overview of the epidemiology trends of Chemotherapy Induced Anemia in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years ...

$ 2950


Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anemia in Chronic Kidney Disease (Renal Anemia) - Pip...

$ 2000

Email Us
Need Help?
Name
Email
Phone
Country
Subject
Comments

Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Use our subscription option and keep yourself updated about the latest industry analysis reports. We have research reports for over 5000 micro markets; you can access and utilize them at economical budgets.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: